Showing results (121-130 of 205) with videos related to
Sort By:
Pageof 21
Journal of Endocrinological Investigation|November 1, 1982
Effects of gonadotropin-releasing hormone (GnRH) on gastric secretion and gastrin release in the dogG Soldani, M Del Tacca, G Bambini, et al.Research Communications in Chemical Pathology and Pharmacology|January 1, 1990
Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenaseP G Gervasi, M R Agrillo, A Lippi, et al.Toxicology|January 1, 1991
Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicinR Danesi, N Bernardini, C Agen, et al.Pharmacological Research|September 1, 1995
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell linesA di Paolo, G Bocci, F Innocenti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluationG Bocci, M Tuccori, U Emmenegger, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|January 1, 1994
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicinA Pinna, C Agen, A Di Paolo, et al.Therapeutic Drug Monitoring|June 12, 1999
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasmaS Fogli, R Danesi, F Innocenti, et al.Cancer Chemotherapy and Pharmacology|January 29, 1999
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivoG Bocci, R Danesi, U Benelli, et al.Journal of Chemotherapy (Florence, Italy)|July 23, 2009
Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infectionsC Tascini, E Tagliaferri, A Di Paolo, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in miceF Innocenti, R Danesi, A Di Paolo, et al.Pageof 21